18 drug(s) with this reaction
12,249 total reports
Depression has been reported as an adverse reaction across 18 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 12,249 adverse event reports mention depression in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with depression, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have depression listed in their FDA adverse event reports, sorted by report count:
In addition to depression, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
18 drug(s) manufactured by Haleon Us Holdings Llc have depression listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
There are a combined 12,249 reports of depression across 18 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.